US4837030A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Novel controlled release formulations of tetracycline compounds
Assignee: Wyeth Holdings LLC
•
Filing: 1987-10-06
•
Granted: 1989-06-06
•
Expires: 2007-10-06
Abstract
Abstract Pharmaceutical compositions comprising spherical granules including thereon or therein a 7- or 9-akylamino-6-deoxy-6-demethyltetracycline or an acid-addition salt thereof blended with at least one excipient are adapted to control the rate of drug release in the stomach and in the intenstine in order not to produce nausea or dizziness upon oral administration during antibacterial therapy.
Inventors
- 👤 Joseph J. Valorose, Jr.
- 👤 Raymond J. Biehl
- 👤 Nitin V. Sheth
- 👤 Walter A. Strathy
- 👤 Michael K. Doelling
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-03 16:17
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/65; A61K9/00; A61K9/14; A61K9/16; A61K9/1605; A61K9/1629; A61K9/1652; A61K9/20; A61K9/48; A61K9/50; A61K9/5073; A61K9/5078; A61P; A61P31/00; A61P31/04
Claims Analysis
Total Claims: 44
Claim 1
Independent Claim
68 words
A spheronized pharmaceutical composition spherical comprising granules which include on or in said granules an effective antibacterial amount of a 7- or 9-(lower)alkylamino-6-deoxy-6-demethyltetracycline or a non-toxic acid addition said thereof blended with an effective amount of at least one pharmaceutically acceptable excipient, said granules being adapted to control the rate of release of said 7- or 9-(lower)alkylamino-6-deoxy-6-demethyl tetracycline in the human stomach and human intesting upon oral administration.
Claim 2
Dependent Claim
68 words
A spheronized pharmaceutical composition spherical comprising granules which include on or in said granules an effective antibacterial amount of a 7- or 9-(lower)alkylamino-6-deoxy-6-demethyltetracycline or a non-toxic acid addition said thereof blended with an effective amount of at least one pharmaceutically acceptable excipient, said granules being adapted to control the rate of release of said 7- or 9-(lower)alkylamino-6-deoxy-6-demethyl tetracycline in the human stomach and human intesting upon oral administration.
Claim 3
Dependent Claim
44 words
A pharmaceutical composition as defined in claim 1 wherein controlling the rate comprises retarding the rate of release of said 7- or 9-(lower)alkyl-amino-6-deoxy-6-demethyl tetracycline compound in the human stomach and promoting rapid release of said tetracycline compound in the human intestine upon oral administration.
Claim 4
Dependent Claim
49 words
A pharmaceutical composition as defined in claim 1 wherein each of said spherical granules includes an ultrathin layer of a polymer substantially uniformly coating each of said spherical granules, said polymer being slowly erodable in the human stomach and rapidly erodable in the human small intestine upon oral administration.
Claim 5
Dependent Claim
57 words
A pharmaceutical composition as defined in claim 1 wherein said 7- or 9-(lower)alkylamino-6-deoxy-6-demethyl tetracycline compound is substantially completely released from said spherical granules in not less than about 20 minutes nor more than about 90 minutes when suspended in deionized water at ambient temperature at a drug concentration of about 100 mg of drug/900 ml of water.
Claim 6
Dependent Claim
55 words
A pharmaceutical composition as defined in claim 3 wherein said 7- or 9-(lower)alkylamino-6-deoxy-6-demethyl tetracycline compound is substantially completely released from said spherical granules in not less than about 20 minutes nor more than about 90 minutes when suspended in deionized water at ambient temperature at a drug concention of about 100 mg/900 ml of water.
Claim 7
Dependent Claim
45 words
A pharmaceutical composition as defined in claim 1 wherein said 7- or 9-(lower)alkylamino-6-deoxy-6-demethyl tetracycline is selected from (a) 7-dimethylamino-6-deoxy-6-demethyl tetracyline; (b) 7-methylamino-6-deoxy-6-demethyltetracycline; (c) 9-methylamino-6-deoxy-6-demethyltetracycline; (d) 7-ethylamino-6-deoxy-6-demethyltetracycline; (e) 7-iospropylamino-6-deoxy-6-demethyltetracyline; (f) a non-toxic acid addition salt of (a)-(e) inclusive; or (g) a mixture of any of (a)-(f).
Claim 8
Dependent Claim
25 words
A pharmaceutical composition as defined in claim 6 wherein said 7- or 9-(lower)alkylamino-6-deoxy-6-demethyl tetracycline compound is selected from 7-dimethylamino-6-deoxy-6-demethyltetracycline or an acid addition salt thereof.
Claim 9
Dependent Claim
18 words
A pharmaceutical composition as defined in claim 7 wherein said 7- or 9-(lower)alkylamino-6-deoxy-6-demethyl tetracycline compound comprises 7-dimethylamino-6-deoxy-6-demethyltetracycline hydrochloride.
Claim 10
Dependent Claim
41 words
A pharmaceutical composition as defined in claim 1 wherein said pharmaceutical excipient comprises microcrystalline cellulose, polyvinylpyrrolidone, hydroxypropylmethyl cellulose, microcrystalline cellulose in combination with lactose, microcrystalline cellulose in combination with sodium carboxymethyl cellulose, or a mixture of any of said pharmaceutical excipients.
Claim 11
Dependent Claim
15 words
A pharmaceutical composition as defined in claim 9 wherein said pharmaceutical excipient comprises microcrystalline cellulose.
Claim 12
Dependent Claim
39 words
A pharmaceutical composition as defined in claim 3 wherein said pharmaceutical excipient comprises microcrystalline cellulose, polyvinylpyrrolidone, hydroxypropylmethyl cellulose, microcrystalline cellulose in combination with lactose, microcrystalline cellulose in combination with sodium carboxymethylcellulose, or a mixture of any of the foregoing.
Claim 13
Dependent Claim
15 words
A pharmaceutical composition as defined in claim 11 wherein said pharmaceutical excipient comprises microcrystalline cellulose.
Claim 14
Dependent Claim
53 words
A pharmaceutical composition as defined in claim 1 wherein said 7- or 9-(lower)alkyl-amino-6-deoxy-6-demethyl tetracycline compound comprises from about 10 to about 70 parts by weight and said excipient comprises from about 90 to about 30 parts by weight per 100 parts by weight of said 7- or 9-(lower)alkyl-amino-6-deoxy-6-demethyl tetracycline compound and said excipient.
Claim 15
Dependent Claim
48 words
A pharmaceutical composition as defined in claim 3 wherein wherein said tetracycline compound comprises from about 10 to about 70 parts by weight and said excipient comprises from about 90 to about 30 parts by weight per 100 parts by weight of said tetracycline compound and said excipient.
Claim 16
Dependent Claim
72 words
A pharmaceutical composition as defined in claim 3 wherein said polymer is selected from (a) methylcellulose; (b) ethylcellulose; (c) hydroxyethyl cellulose; (d) hydroxypropyl cellulose; (e) hydroxypropyl methylcellulose; (f) hydroxypropyl methylcellulose phthalate; (g) cellulose acetate phthalate (h) hydroxypropyl methylcellulose succinate (i) a polymer or copolymer of (meth)acrylic acid or an ester thereof; or (j) a mixture of any of (a)-(i) alone or in further combination with a plasticizer, a colorant or a pigment.
Claim 17
Dependent Claim
27 words
A pharmaceutical composition as defined in claim 3 which also includes an ultrathin top layer of the same or a different polymer over an intermediate polymer layer.
Claim 18
Dependent Claim
19 words
A pharmaceutical composition as defined in claim 16 wherein the intermediate layer and the top layer comprise hydroxypropyl methylcellulose.
Claim 19
Dependent Claim
32 words
A pharmaceutical composition as defined in claim 3 wherein said polymer comprises from about 2 to less than about 10 percent by weight of the total weight of said polymer-coated spherical granules.
Claim 20
Dependent Claim
29 words
A pharmaceutical composition as defined in claim 18 wherein said polymer comprises from about 2 to about 5 percent by weight of the weight of said polymer-control spherical granules.
Claim 21
Dependent Claim
27 words
A pharmaceutical composition as defined in claim 1 wherein the spherical granules have an average diameter in the range of from about 0.1 to about 2.5 millimeters.
Claim 22
Dependent Claim
24 words
A pharmaceutical composition as defined in claim 20 wherein the spherical granules have an average diameter of from about 0.8 to about 1.2 millimeters.
Claim 23
Dependent Claim
106 words
A controlled release pharmaceutical composition in oral dosage unit form comprising A. A gelatin capsule filled solely with B. beads having an average diameter of from about 0.1 to about 2.5 millimeters, each bead being similar in composition and comprising spherical granules which include on or in said granules an effective antibacterial amount of a 7- or 9-(lower)alkylamino-6-deoxy-6-demethyltetracycline or a non-toxic acid addition salt thereof blended with an effective amount of at least one pharmaceutically acceptable excipient, said granules being adapted to control the rate of release of said 7- or 9-(lower)alkyl-amino-6-deoxy-6-demethyl tetracycline compound in the human stomach and in the human intestine upon oral administration.
Claim 24
Dependent Claim
106 words
A controlled release pharmaceutical composition in oral dosage unit form comprising A. A gelatin capsule filled solely with B. beads having an average diameter of from about 0.1 to about 2.5 millimeters, each bead being similar in composition and comprising spherical granules which include on or in said granules an effective antibacterial amount of a 7- or 9-(lower)alkylamino-6-deoxy-6-demethyltetracycline or a non-toxic acid addition salt thereof blended with an effective amount of at least one pharmaceutically acceptable excipient, said granules being adapted to control the rate of release of said 7- or 9-(lower)alkyl-amino-6-deoxy-6-demethyl tetracycline compound in the human stomach and in the human intestine upon oral administration.
Claim 25
Dependent Claim
49 words
A control release pharmaceutical composition as defined in claim 22 wherein controlling the rate comprises retarding the rate of release of said 7- or 9-(lower)alkyl-amino-6-deoxy-6-demethyl tetracycline compound in the human stomach and promoting rapid release of said 7- or 9-(lower)alkyl-amino-6-deoxy-6-demethyl tetracycline compound in the human intesting upon oral administration.
Claim 26
Dependent Claim
51 words
A controlling release pharmaceutical composition as defined in claim 22 wherein each of said spherical granules includes an ultrathin layer of a polymer substantially uniformly coating each of said spherical granules, said polymer being slowly erodable in the human stomach and rapidly erodable in the human small intestine upon oral administration.
Claim 27
Dependent Claim
48 words
A controlled release pharmaceutical composition as defined in claim 22 wherein said 7- or 9-(lower)alkyl-amino-6-deoxy-6-demethyl tetracycline compound is selected from (a) 7-dimethylamino-6-deoxy-6-demethyl tetracyline; (b) 7-methylamino-6-deoxy-6-dimethyltetracycline; (c) 9-methylamino-6-deoxy-6-demethyltetracycline; (d) 7-ethylamino-6-deoxy-6-demethyltetracycline; (e) 7-isopropylamino-6-deoxy-6-demethyltetracycline; (f) a non-toxic acid addition salt of (a)-(e), inclusive; or (g) a mixture of any of (a)-(f).
Claim 28
Dependent Claim
28 words
A controlled release pharmaceutical composition as defined in claim 25 wherein said 7- or 9-(lower)alkyl-amino-6-deoxy-6-demethyl tetracycline compound is selected from 7-dimethylamino6-deoxy-6-demethyl tetracycline or an acid addition salt thereof.
Claim 29
Dependent Claim
19 words
A controlled release pharmaceutical composition as defined in claim 26 wherein said 7- or 9-(lower)alkyl-amino-6-deoxy-6-tetracycline compound comprises 7-dimethylamino-6-deoxy-6-demethyltetracycline hydrochloride.
Claim 30
Dependent Claim
42 words
A controlled release pharmaceutical composition as defined in claim 22 wherein said pharmaceutical excipient comprises microcrystalline cellulose, polyvinylpyrrolidone, hydroxypropylmethyl cellulose, microcrystalline cellulose in combination with lactose, microcrystalline cellulose in combination with sodium carboxymethyl-cellulose, or a mixture of any of said pharmaceutical excipients.
Claim 31
Dependent Claim
17 words
A controlled release pharmaceutical composition as defined in claim 28 wherein said pharmaceutical excipient comprises microcrystalline cellulose.
Claim 32
Dependent Claim
43 words
A controlled release pharmaceutical composition as defined in claim 24 wherein said pharmaceutical excipient comprises microcrystalline cellulose, polyvinyl pyrrolidone, hydroxypropylmethyl cellulose, microcrystalline cellulose in combination with lactose, microcrystalline cellulose in combination with sodium carboxymethyl-cellulose, or a mixture of any of said pharmaceutical excipients.
Claim 33
Dependent Claim
17 words
A controlled release pharmaceutical composition as defined in claim 30 wherein said pharmaceutical excipient comprises microcrystalline cellulose.
Claim 34
Dependent Claim
58 words
A controlled release pharmaceutical composition as defined in claim 22 wherein in beads B said 7- or 9-(lower)alkyl-amino-6-deoxy-6-demethyl tetracycline compound comprises from about 10 to about 70 parts by weight and said excipient comprises from about 90 to about 30 parts by weight per 100 parts by weight of said 7- or 9-(lower)alkyl-amino-6-deoxy-6-demethyl tetracycline compound and said excipient.
Claim 35
Dependent Claim
54 words
A controlled release composition as defined in claim 24 wherein said beads B said 7- or 9-(lower)alkyl-amino-6-deoxy-6-demethyl tetracycline compound comprises from about 10 to about 70 parts by weight and said excipient comprises from about 90 to about 30 parts by weight per 100 parts by weight of said tetracycline compound and said excipient.
Claim 36
Dependent Claim
74 words
A controlled release pharmaceutical composition as defined in claim 22 wherein wherein said polymer is selected from (a) methylcellulose; (b) ethylcellulose; (c) hydroxyethyl cellulose; (d) hydroxypropyl cellulose; (e) hydroxypropyl methylcellulose; (f) hydroxypropyl methylcellulose phthalate; (g) cellulose acetate phthalte (h) hydroxypropyl methylcellulose succinate (i) a polymer or copolymer of (meth)acrylic acid or an ester thereof; or (j) a mixture of any of (a)-(i), or in further combination with a plasticizer, a colorant or a pigment.
Claim 37
Dependent Claim
29 words
A controlled release pharmaceutical composition as defined in claim 24 wherein beads B also include an ultrathin top layer of the same or a different polymer over intermediate layer.
Claim 38
Dependent Claim
21 words
A controlled release pharmaceutical composition as defined in claim 35 wherein the intermediate layer and the top layer comprise hydroxypropyl methylcellulose.
Claim 39
Dependent Claim
34 words
A controlled release pharmaceutical composition as defined in claim 24 wherein said polymer comprises from about 2 to less than about 10 percent by weight of the total weight of said polymer coated spheres.
Claim 40
Dependent Claim
28 words
A controlled release pharmaceutical composition as defined in claim 37 wherein said polymer comprises from about 2 to about 5 percent by weight of said polymer coated spheres.
Claim 41
Dependent Claim
25 words
A controlled release pharmaceutical composition as defined in claim 22 wherein said beads have an average diameter of from about 0.1 to about 2.5 millimeters.
Claim 42
Dependent Claim
27 words
A controlled release pharmaceutical composition as defined in claim 22 wherein each capsule contains from about 25 to about 200 mg of 7- or 9-(lower)alkyl-amino-6-deoxy-6-demethyl tetracycline compound.
Claim 43
Dependent Claim
26 words
A controlled release pharmaceutical composition as defined in claim 24 wherein each capsule contains from about 25 to about 200 of 7- or 9-(lower)alkyl-amino-6-deoxy-6-demethyl tetracycline compound.
Claim 44
Dependent Claim
18 words
A controlled release pharmaceutical composition as defined in claim 1 in oral dosage unit form comprising a tablet.
References Cited (Backward Citations)
US4207258A
Cited
US4038315A
Cited
US3901942A
Cited
US3960757A
Cited
US4154827A
Cited
US4622244A
Cited
US4500458A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-06-05 | 1992-12-05 | 1993-06-06 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-06-05 | 1996-12-05 | 1997-06-06 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-06-05 | 2000-12-05 | 2001-06-06 | $7700.00 | Window Closed / Lapsed |